Publication date: Available online 6 October 2026 Source: European Urology Oncology Author(s): Michael Baboudjian, Alessandro Uleri, Giuseppe Fallara, Alberto Martini, Guillaume Ploussard
Metastasis-free Survival in High-risk Prostate Cancer: A Valid Surrogate, but Is it Transportable Across Strategies of Unequal Systemic Exposure?. // European Urology Oncology. – URL: https://www.sciencedirect.com/science/article/pii/S2588931126002622?dgcid=rss_sd_all
Metastasis-free Survival in High-risk Prostate Cancer: A Valid Surrogate, but Is it Transportable Across Strategies of Unequal Systemic Exposure?. European Urology Oncology. https://www.sciencedirect.com/science/article/pii/S2588931126002622?dgcid=rss_sd_all
“Metastasis-free Survival in High-risk Prostate Cancer: A Valid Surrogate, but Is it Transportable Across Strategies of Unequal Systemic Exposure?.” European Urology Oncology.
@article{article45681,
title = {Metastasis-free Survival in High-risk Prostate Cancer: A Valid Surrogate, but Is it Transportable Across Strategies of Unequal Systemic Exposure?},
journal = {European Urology Oncology},
url = {https://www.sciencedirect.com/science/article/pii/S2588931126002622?dgcid=rss_sd_all}
}
Objective To assess prostate‐specific antigen (PSA) testing according to income, age, and region of residence in Sweden. Patients and Methods We conducted a nationwide, population‐based open cohort study of men aged 40–90 years in...